Primrose Bio, Inc. ("Primrose"), a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApolstm ExTend, an RNA polymerase engineered to significantly ...

Sometimes, a little encouragement can make a big difference. At Freedom Elementary, fourth-grader Yovani Velasco-Morelos ...

Research and development expenses include $2.6 million and $13.5 million of non-cash stock-based compensation expenses for the fourth quarter and fiscal year 2024, respectively, as compared to $5. ...

2025--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today reported financial results for the fourth quarter ...

BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq ... today reported financial results and operational highlights for the fourth quarter and year ended December 31, 2024.

Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its fourth quarter and full year 2024 ...

“We are pleased to have closed out 2024 with record fourth quarter sales and gross margin performance, demonstrating the momentum in our business,” said Robert Spignesi, President and CEO.

Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report ...

TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Fourth Quarter Earnings Conference Call ...

PRINCETON, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

A webcast of the call will also be available on the Investor Relations page of Oncolytics’ website, available by clicking here, and will be archived for three months. A dial-in replay will be ...